Gordon and co. havent quoted any prices beyond saying that Stelfonta treatment will cost the equivalent or not exceed current SOC (standard of care) prices, eg. surgery etc. Know that the split is 50/50 with Virbac.
They are waiting on FDA, obviously. A quote from keith Pointon, Qbiotics point of contact, when I inquired
'All ‘packages’ are with FDA. They are a law unto themselves as to timing. We have not been advised of any issues to date. We are hopeful of approval before years end'
The relevant Australian authority is as tardy as usual, which is more stupefying.
Also maybe you are aware of the Pitt Street Biotech meet early this year during which Rick Holliday Smith, Chairman of Qbiotics, brought up TT. He said that on the initial submission the FDA were incredulous of the (vet) trial results and required further clarification. The standard 'waterfall plot' of the results were a rarity, even never observed before. Literally needed to be seen to be believed, lol.
However, it seems bizarre that now your dog can get a cure for its cancer (in Europe for now) but you cant.
